Brand Name: LANSOPRAZOLE
Generic Name: Lansoprazole USP
Available Strengths:
Lansoprazole 15mg/30 mg (as enteric coated pellets)
Lansoprazole Delayed-Release (DR) Capsules are advanced proton pump inhibitors (PPIs) designed for the management of acid-related gastrointestinal conditions, including gastroesophageal reflux disease (GERD), peptic and duodenal ulcers, and Zollinger-Ellison syndrome. The delayed-release formulation ensures the active ingredient passes through the stomach and dissolves in the intestine, improving absorption and therapeutic efficacy. Lansoprazole works by selectively inhibiting proton pumps in the gastric lining, reducing acid secretion and promoting healing of the gastrointestinal mucosa. Manufactured under stringent quality standards, these capsules provide reliable, long-lasting relief from heartburn, acid reflux, and other gastric discomforts when taken as prescribed by a healthcare professional.
Capabilities Offered:
Ready dossier for both strengths in CTD/ ACTD format
Third party manufacturing services
Contract Manufacturing (CMO Services)
Formulation Development Services
Regulatory & Documentation Support
Export / Licensing Services
In addition to the products listed on our website, we possess the technical capability and infrastructure to develop and manufacture customized formulations as per your specific requirements and regulatory markets.
For business inquiries, email at sales@cooperpharma.com